Series B - Eureka Therapeutics
Investment Firm
Overview
Eureka Therapeutics is a biotechnology company that develops T-cell therapies.
Announced Date
Nov 13, 2008
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Acorn Campus Ventures |
Round Details and Background
Eureka Therapeutics raised $1700000 on 2008-11-13 in Series B
Eureka Therapeutics is a biotechnology company that develops T-cell therapies.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 16, 2007 |  Pre Seed Round - Eureka Therapeutics | - | 1.4K | |
| Aug 01, 2007 | Series A - Eureka Therapeutics | - | 1.2M | |
| Nov 13, 2008 | Series B - Eureka Therapeutics | 1 | - | 1.7M |
| Sep 23, 2014 | Series C - Eureka Therapeutics | 5 | - | 21.0M |
Recent Activity
There is no recent news or activity for this profile.